Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Histone deacetylase 1 (HDAC1) is a co-repressor involved in differentiation and proliferation control. It is upregulated in malignant compared to benign tissue, and targets a number of transcription factors including p53. METHODS: By immunohistochemistry, HDAC1 protein expression was investigated in human prostate specimens and the CWR22 mouse xenograft model. Flow cytometry and deconvolution immunofluorescence were also performed. RESULTS: HDAC1 was upregulated in pre-malignant and malignant lesions, with the highest increase in expression in hormone refractory (HR) cancer. Using the CWR22 xenograft model we showed androgen dependent regulation of HDAC1. HDAC1 overexpression led to a significant increase in proliferation and a shift towards the undifferentiated cytokeratin (CK) profile in a PC3M derivative clone constitutively expressing HDAC1. CONCLUSION: This study underlines the importance of HDAC1 in cell proliferation and the development of prostate cancer (CaP) and proposes a mechanism for HDAC1 nuclear recruitment. HDAC1 may constitute a crucial therapeutic target particularly in the most lethal phase of androgen independence.

Original publication

DOI

10.1002/pros.20022

Type

Journal article

Journal

Prostate

Publication Date

01/05/2004

Volume

59

Pages

177 - 189

Keywords

Androgens, Animals, Antineoplastic Agents, Hormonal, Blotting, Western, Cell Division, Cell Nucleus, Cytokines, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Histone Deacetylase 1, Histone Deacetylases, Humans, Immunohistochemistry, Male, Mice, Mice, Nude, Prostatic Neoplasms, Transplantation, Heterologous, Up-Regulation